InSCREENeX offers highly customized cell lines and cell line services for drug discovery and development. We specialize in immortalized cell lines and stable cells. | InSCREENex GmbH is a German biotechnology company specializing in the development of advanced mammalian cell models to accelerate drug discovery and development. Founded in 2009, InSCREENex offers customized stable cell lines and immortalized primary cells, supporting applications from high-throughput screening to disease modeling. With a strong focus on tailored solutions, InSCREENex enables pharmaceutical and biotech partners worldwide to enhance research and innovation. | Inscreenex creates custom cell lines for pharma and biotech, including immortalization, gene overexpression, gene knockout, and reporter lines.
Industrial Technology Research Institute (ITRI)
ITRI is committed to driving the development of various industries with its outstanding technology and research abilities in hopes to create economic values and promote social well-being. In addition to playing a role of researcher and developer in the fields of medicine as well as medical devices, it has also established a complete structure of CRO (Contract Research Organizations) and CDMO (Contract Development & Manufacturing Organization) services. The one-stop biomedical services platform of ITRI provides assistance in a wide range of scopes, including research and development, model translation, GXP trial production, pre-clinical/clinical trial, post-marketing consultation, etc. This mechanism makes it possible for domestic manufacturers to lower their initial cost of investment, and accelerate their research and development. ◆ Regulation Consulting: FDA/TFDA/CE application, medical device verification/export, medical device/medicine registration, IRB document organization, clinical trial application, and more. ◆ Licencing: Bio-IT, diagnostics and precision medicine technology, regeneration medicine technology, natural medicine and healthcare technology, targeted drug and delivery technology. ◆ Prototyping: Domestic supply chain linkage, medical device design control, market analysis, strategy analysis of regulation in commercialization, and more. ◆ Preclinical/Clinical Trial: Functional safety assessments, clinical research organization linkage, clinical evaluation and analysis, clinical trial planning, clinical trial analysis and reports. ◆ Other Services: Quality system consulting, commercialization consulting, smart health solutions, software validation, medical device risk management, information security risk evaluation, technical documents preparation, business ecosystem linkage, and more.
Indiana Pavillion
The Indiana Pavilion is brought to you by BioCrosscrossroads. BioCrossroads is a catalyst for Indiana’s diverse and growing life sciences industry, supporting collaboration, expertise, and investments that fuel innovation and transform global health.
HIPRA Biotech Services
HIPRA Biotech Services is a CDMO supporting pharmaceutical and biotech companies across the full early clinical to commercial lifecycle of biologic and vaccine products. Backed by over 50 years of scientific and technical excellence including our internally commercialized and marketed COVID vaccine, we offer end-to-end development and GMP manufacturing solutions across a wide range of expression platforms, from viral to mammalian to microbial platforms, to make clinical and commercial drug substance and drug product for our clients. With a team of 450+ R&D scientists and over 1,000+ professionals in Manufacturing, QA and QC, state-of-the-art facilities, and a strong regulatory track record, we deliver both clinical and commercial programs with speed, quality, and flexibility. We continuously invest in innovation and capacity expansion, making us a trusted partner that will grow with our clients for their long-term success. https://www.hipra.com/en/cdmo-services
GCCL
Accelerate your global trials with GCCL – All-in-One Clinical Lab Solution (Central Lab + BA Lab + R&D) GCCL, a Lab CRO based in South Korea, specializing in clinical sample analysis services for all phases of trials. With an exclusive lab service available for clinical trials and a logistics system that meets global quality standards, GCCL is building trust with over 200 partners globally by providing a sample analysis and bioanalytical service spanning the entire cycle of clinical trials to meet customer demands. Based in Korea as a strategic hub for the Asia-Pacific region, GCCL is South Korea’s only provider of a fully integrated “all-in-one lab solution,” combining a Central Lab, Bioanalytical Lab, and Biosafety Level 3/2 (BL3) facilities. This unified approach delivers consistent analytical quality, reliable data, and reduced time and costs by minimizing sample handling. Leveraging its proprietary G-HUB IT platform, cutting-edge analytical technologies, and global LIMS, GCCL provides end-to-end, high-quality clinical sample analysis services—from collection to storage—positioning itself as a trusted partner in drug development. Its dedicated R&D lab drives method development, biomarker discovery, and the evaluation of innovative analytical technologies, continuously enhancing capabilities to meet evolving clinical trial needs. -Supporting clinical trials with comprehensive laboratory services across all therapeutic areas and pipelines (from sample collection and kit production to analysis and storage) -Collaborating on R&D for pipelines, including biosimilars, bioanalysis, assays, and more -Offering clinical trial consulting, including study design and regulatory/approval support
Fluid Air
Established in 1983, Fluid Air serves companies that manufacture powdered products and ingredients, in industries including biopharmaceutical, advanced batteries, nutraceutical, food, fine chemicals, and agriculture. Our PolarDry® electrostatic drying system allows customers to bypass the inherent constraints of freeze drying and conventional spray drying, achieving scalable production and lower costs. Learn more about Fluid Air at www.fluidairinc.com.
eXmoor Pharma
eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years CMC consultancy experience, supporting over 150 organisations to accelerate novel therapies from discovery to patients. We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the chances of product success. | eXmoor Pharma is a full-service Cell & Gene Therapy CDMO with a difference. Backed by over 20 years of consultancy experience, we’ve helped more than 170 organisations accelerate therapies from discovery to delivery. We deliver more than manufacturing. Our integrated consultancy and technical development services span the full journey from early-phase strategy to GMP manufacturing and commercialisation. Our in-house experts work as an extension of your team, helping you plan, scale, and deliver therapies that are clinically and commercially viable. We bring deep domain knowledge across process development, analytical science, facility design, GMP production, and regulatory strategy. With a purpose-built facility and a commitment to full IP freedom, we give innovators the space and flexibility to focus on what matters most: getting life-changing treatments to patients faster.
ExcellGene
ExcellGene is a leading biotechnology company specializing in developing and producing high-quality recombinant proteins and monoclonal antibodies, with expertise in CHO and HEK-293 cell lines. With over 20 years of experience in the field, our dedicated team of experts ensures reliable, timely, and efficient customized solutions meeting the highest quality standards for a wide range of research, diagnostic, and therapeutic applications. Visit our booth #1743 to learn more about our services and products, and go to www.excellgene.com for additional information or to get in touch. | ExcellGene is a leading biotechnology company specializing in developing and producing high-quality recombinant proteins and monoclonal antibodies, with expertise in CHO and HEK-293 cell lines. With over 20 years of experience in the field, our dedicated team of experts ensures reliable, timely, and efficient customized solutions meeting the highest quality standards for a wide range of research, diagnostic, and therapeutic applications. | Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.